ArticleScience advances2025
Organocatalyzed atroposelective dynamic kinetic resolutions via transient seven-membered cyclic hemiacetals.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Catalytic atroposelective dynamic kinetic resolution via the formation of transient bridged biaryl intermediates represents an expedient route for the synthesis of axially chiral biaryls. Progress in this field has been limited to the reactions promoted by bridged biaryl intermediates with five- or six-membered rings. Herein we demonstrate the first example of a carbene-catalyzed atroposelective dynamic kinetic acylation reaction via transient seven-membered cyclic hemiacetals. The key for the success of this reaction relies on the formation and configurational instability of the transient seven-membered cyclic hemiacetal intermediate. The axially chiral biaryl aldehyde products obtained via this method can undergo a series of further transformations. Notably, one of the axially chiral biaryl aldehyde products can be used as the key and common intermediate for the asymmetric synthesis of natural product steganone. Preliminary density functional theory calculations reveal the molecular origins underlying the observed chemo- and enantioselectivity outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.